Literature DB >> 16397542

Decoy receptor springs to life and eases fibrosis.

Thomas T MacDonald.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16397542     DOI: 10.1038/nm0106-13

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  10 in total

1.  Resolvin E1 reduces hepatic fibrosis in mice with Schistosoma japonicum infection.

Authors:  Wenhong Qiu; Kaiwen Guo; Luyang Yi; Yeli Gong; Lixia Huang; Wei Zhong
Journal:  Exp Ther Med       Date:  2014-03-27       Impact factor: 2.447

2.  The clinical and immunologic features of pulmonary fibrosis in sarcoidosis.

Authors:  Karen C Patterson; Kyle Hogarth; Aliya N Husain; Anne I Sperling; Timothy B Niewold
Journal:  Transl Res       Date:  2012-04-10       Impact factor: 7.012

3.  Nodal signaling activates differentiation genes during zebrafish gastrulation.

Authors:  James T Bennett; Katherine Joubin; Simon Cheng; Pia Aanstad; Ralf Herwig; Matthew Clark; Hans Lehrach; Alexander F Schier
Journal:  Dev Biol       Date:  2007-01-12       Impact factor: 3.582

4.  Gene Therapy against Murine Melanoma B16F10-Nex2 Using IL-13Ralpha2-Fc Chimera and Interleukin 12 in Association with a Cyclopalladated Drug.

Authors:  Flavia Hebeler-Barbosa; Elaine G Rodrigues; Rosana Puccia; Antonio Cf Caires; Luiz R Travassos
Journal:  Transl Oncol       Date:  2008-09       Impact factor: 4.243

Review 5.  The IL-4/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets.

Authors:  Julie K Nguyen; Evan Austin; Alisen Huang; Andrew Mamalis; Jared Jagdeo
Journal:  Arch Dermatol Res       Date:  2019-09-06       Impact factor: 3.017

Review 6.  Revisiting fibrosis in inflammatory bowel disease: the gut thickens.

Authors:  Silvia D'Alessio; Federica Ungaro; Daniele Noviello; Sara Lovisa; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-12-07       Impact factor: 46.802

7.  Glioma IL13Rα2 is associated with mesenchymal signature gene expression and poor patient prognosis.

Authors:  Christine E Brown; Charles D Warden; Renate Starr; Xutao Deng; Behnam Badie; Yate-Ching Yuan; Stephen J Forman; Michael E Barish
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

Review 8.  Interleukin-4 Receptor Alpha: From Innate to Adaptive Immunity in Murine Models of Cutaneous Leishmaniasis.

Authors:  Ramona Hurdayal; Frank Brombacher
Journal:  Front Immunol       Date:  2017-11-10       Impact factor: 7.561

Review 9.  Sarcoidosis: Progression to the chronic stage and pathogenic based treatment (narrative review).

Authors:  Anna Malkova; Yulia Zinchenko; Anna Starshinova; Dmitriy Kudlay; Igor Kudryavtsev; Anzhela Glushkova; Piotr Yablonskiy; Yehuda Shoenfeld
Journal:  Front Med (Lausanne)       Date:  2022-09-06

10.  Targeting of interleukin-13 receptor α2 for treatment of head and neck squamous cell carcinoma induced by conditional deletion of TGF-β and PTEN signaling.

Authors:  Bradford Hall; Hideyuki Nakashima; Zhi-Jun Sun; Yuki Sato; Yansong Bian; Syed R Husain; Raj K Puri; Ashok B Kulkarni
Journal:  J Transl Med       Date:  2013-02-19       Impact factor: 5.531

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.